Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The ongoing problem of emerging antimicrobial resistance has been likened to a balloon where settling one specific issue results in a ‘bulge’ of even worse problems. However, much has been learned about how to best use our critical antibacterial agents in ways to avoid or even repair some of the resistance damage that has been done. A compilation of current literature strongly suggests that to slow the development of resistance to antimicrobial agents it is optimal to use drugs with more than one mechanism of action or target, to prescribe those with demonstrated ability to minimise or reverse resistance problems, and to avoid underdosing of potent antibiotics. The most recent information also indicates that it is best to limit empirical use of β-lactam plus fluoroquinolone combination therapy, since these two classes activate some common resistance responses, and using them together can facilitate multidrug resistance in important pathogens, particularly Pseudomonas aeruginosa and Acinetobacter species. This review discusses the role of each major antimicrobial class on resistance development and presents specific strategies for combating the growing problem of multidrug-resistant bacteria. We now have the knowledge to better manage our antimicrobial agent prescribing practices, but finding the will and resources to apply our understanding remains a formidable challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834 · cited 1×
“More than 10 years ago, Dr Harold Neu sounded the alarm over increasing antibiotic resistance [5] .”
BackgroundVariation in antibiotic use in the European Union
Cars, O., Mölstad, S., & Melander, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04972-2 · Cited by 698
Trends in β‐Lactam Resistance Among Enterobacteriaceae
Nordmann, P. (1998) · Clinical Infectious Diseases · doi:10.1086/514905 · Cited by 124 · cited 3×
“In addition to being potent inhibitors of Ambler class A (plasmid-mediated) b-lactamases [30, 38, 39] , they have been shown to contribute additional effects by binding to accessory penicillin-binding proteins, the key targets of penicillin compounds.”
Background
Cited by
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Falagas, M. E., Tansarli, G. S., Ikawa, K., & Vardakas, K. Z. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis857 · Cited by 283
β-Lactam resistance and β-lactamases in bacteria of animal origin
Li, X.-Z., Mehrotra, M., Ghimire, S., & Adewoye, L. (2007) · Veterinary Microbiology · doi:10.1016/j.vetmic.2007.01.015 · Cited by 266
Acinetobacter baumannii: a universal threat to public health?
Giamarellou, H., Antoniadou, A., & Kanellakopoulou, K. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.02.013 · Cited by 258
Schweitzer, V. A., van Werkhoven, C. H., Rodríguez Baño, J., Bielicki, J., Harbarth, S., Hulscher, M., Huttner, B., Islam, J., Little, P., Pulcini, C., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.08.017 · Cited by 73
Metadata
- Authors
- Peterson, L. R.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2005
- Volume
- 11
- Pages
- 4-16
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W1960584352
- Cited by
- 127
- References
- 4
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. https://app.cochat.ai/papers/10.1111/j.1469-0691.2005.01238.x
- The paper
- Peterson, L. R. (2005). Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. Clinical Microbiology and Infection. https://doi.org/10.1111/j.1469-0691.2005.01238.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.